🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for Albuminuria

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study NCT06059664Phase 21 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: Finerenone Oral Tablet, Placebo Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa NCT05881447n/a1 site📍 Bagamoyo Swiss Tropical & Public Health Institute Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin NCT07175051Phase 21 site📍 Chicago University of Illinois at Chicago · Tests: Empagliflozin (oral) Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) NCT04752293n/a1 site📍 Winston-Salem Wake Forest University Health Sciences Effect Camostat for Kidney Protection in Chronic Kidney Disease NCT06794593Phase 21 site📍 Odense Odense University Hospital · Tests: Camostat Mesylate A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease NCT06830629Phase 279 sites📍 Decatur📍 Huntsville📍 Montgomery Maze Therapeutics · Tests: MZE829 Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease NCT07405216Phase 41 site📍 Aguascalientes Centenario Hospital Miguel Hidalgo · Tests: Dapagliflozin (10mg Tab), Placebo The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease NCT06528405Phase 21 site📍 Taipei National Taiwan University Hospital · Tests: dapagliflozin, Other anti-diabetic drug or no anti-diabetic drug, empagliflozin, canagliflozin Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease NCT07260071n/a1 site📍 London King's College London Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes NCT05498116Phase 41 site📍 Aurora University of Colorado, Denver · Tests: Montelukast, Placebo Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure NCT07259512Phase 41 site📍 Kartasura Evi Liliek Wulandari · Tests: Ramipril Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome NCT07173062NA1 site📍 Porto Universidade do Porto · Tests: Spirulina Arthrospira platensis (microalgae), Gelidium corneum, Placebo Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132n/a13 sites📍 Skejby📍 Copenhagen📍 Hillerød Herlev Hospital · Tests: Kidney Biopsy ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases NCT07187713Phase 41 site📍 Giza Ace Cells Lab Limited · Tests: ACE Reno Time-restricted Eating in Patients With Moderate Chronic Kidney Disease and Albuminuria NCT06618859NA1 site📍 Geneva de Seigneux Sophie · Tests: Time-restricted eating, Active control The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. NCT06600412Phase 21 site📍 Copenhagen River 3 Renal Corp. · Tests: R3R01, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy